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Background: Polyploidy has been recognized for many years as an important hallmark of cancer cells. Polyploid
cells can arise through cell fusion, endoreplication and abortive cell cycle. The inner nuclear membrane protein
LAP2β plays key roles in nuclear envelope breakdown and reassembly during mitosis, initiation of replication and
transcriptional repression. Here we studied the function of LAP2β in the maintenance of cell ploidy state, a role
which has not yet been assigned to this protein.
Results: By knocking down the expression of LAP2β, using both viral and non-viral RNAi approaches in osteosar-
coma derived U2OS cells, we detected enlarged nuclear size, nearly doubling of DNA content and chromosomal
duplications, as analyzed by fluorescent in situ hybridization and spectral karyotyping methodologies. Spectral
karyotyping analyses revealed that near-hexaploid karyotypes of LAP2β knocked down cells consisted of not only
seven duplicated chromosomal markers, as could be anticipated by genome duplication mechanism, but also of
four single chromosomal markers. Furthermore, spectral karyotyping analysis revealed that both of two near-triploid
U2OS sub-clones contained the seven markers that were duplicated in LAP2β knocked down cells, whereas the four
single chromosomal markers were detected only in one of them. Gene expression profiling of LAP2β knocked down
cells revealed that up to a third of the genes exhibiting significant changes in their expression are involved in can-
cer progression.
Conclusions: Our results suggest that nuclear fusion mechanism underlies the polyploidization induction upon
LAP2β reduced expression. Our study implies on a novel role of LAP2β in the maintenance of cell ploidy status.
LAP2β depleted U2OS cells can serve as a model to investigate polyploidy and aneuploidy formation by nuclear
fusion mechanism and its involvement in cancerogenesis.
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Figure 1 LAP2β stable KD in individual U2OS clones. LAP2β
protein and RNA expression levels were evaluated by real time
quantitative (RQ) PCR, normalized to importin (relative
quantification) (A) and western blot analysis of nuclear proteins of
U2OS untreated, scrambled and LAP2β KD clones 1 and 2 with
mouse anti LAP2β and goat anti-β-Actin as loading control (B).
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The nuclear envelope (NE) is an essential structure of all
eukaryotic cells that forms an interactive interface be-
tween the nucleus and cytoplasm, providing anchoring
sites for chromatin domains at the nuclear periphery
and enabling fundamental functions, such as DNA replica-
tion and RNA transcription to be carried out (reviewed in
[1,2]). The NE is a double-unit membrane composed of an
outer nuclear membrane (ONM), an inner nuclear mem-
brane (INM), nuclear pore complexes (NPCs) and nuclear
lamina. The lamins and their INM associating proteins,
such as LBR, LAP2β, MAN1, emerin, and Nesprin-1α,
were shown to be involved in most nuclear activities,
including chromatin organization, DNA replication, tran-
scription regulation, nuclear position, morphology and
mechanical strength of the nucleus during interphase and
governing NE breakdown and reassembly during mitosis
[3-6]. It is now well accepted that these activities which
are highly relevant to tumorigenesis, depending on the
composition and organization of the NE [7].
LAP2β, the most ubiquitous and best studied LAP2
isoform, has been shown to execute some of these func-
tions via its specific binding at the NE to lamin B1, BAF,
GCL, HA95 and HDAC3 [8-11]. The binding of LAP2β
to these partners enables exhibiting its key roles in
nuclear envelope breakdown and reassembly during mi-
tosis, initiation of replication and transcriptional repres-
sion. The latter activity was shown by us to occur as a
result of LAP2β binding to chromatin modifiers, such as
HDAC3, catalyzing gene silencing epigenetic modifica-
tions on histones ([11] and reviewed in [12]). The tran-
scriptional repressive effect of LAP2β was evident on
various cancer related transcription factors, including
E2F5-DP3α, p53 and NFkB [10,11]. Another specific role
of LAP2β in the regulation of nuclear lamina growth
after the completion of NE reassembly and nuclear vol-
ume increase during the cell cycle was suggested earlier
by Yang et al (1997) [13] in HeLa cells and by Gant et al
(1999) [14] in Xenopus laevis extracts. In mitosis, for
proper chromosomal segregation and in order to ensure
that segregated DNA is enveloped in a single cell nu-
cleus in each daughter cell, NE breakdown at early pro-
phase and reassembly at late telophase are crucial
phosphorylation dependent processes governed by the
nuclear lamina, including LAP2β [15]. Indeed, it was
shown by Anderson et al [16] that in U2OS cells re-
duced levels of LBR, LAP2β and MAN1 delayed and
limited but not completely blocked NE formation in a
manner consistent with built-in redundancy. Further-
more, over expression of these proteins accelerated NE
formation, which caused a decrease in chromosome sep-
aration during mitosis [16]. These activities strongly link
the nuclear lamina, including LAP2 proteins, to chromo-
somal stability in healthy cells. Recently it was shownthat NE structural defects due to silencing of lamin A/C
proteins caused chromosomal numerical instability and
aneuploidy in ovarian cancer [17].
These observations led us to hypothesize that the ab-
sence of nuclear lamina components, such as LAP2β,
may cause chromosomal instability and aneuploidy. In
this study we investigated this aspect in U2OS cells
taking the RNAi approach. We found that a reduction in
LAP2β expression induced polyploidy by nuclear fusion
mechanism, suggesting a novel role of an INM pro-
tein in polyploidy formation that may lead to cancer
progression.Results
LAP2β knocked down (KD) U2OS cells are characterized
by doubled DNA content and centromeres duplication
The expression of LAP2β was stably knocked down in
U2OS cells by both, retro-viral infection using the
pSuper-retro vector (Figure 1) and non viral shRNA
using pSuper vector (data not shown). In order to specif-
ically reduce the expression of LAP2β and not the ex-
pression of the other LAP2 isoforms (α, γ, δ, ε and ζ), a
specific shRNA oligonucleotide sequences were designed
based on LAP2β specific sequence of LAP2 gene exon 6.
Western blot analysis of LAP2β KD U2OS cells using
the 6E10 mAb which is common to all LAP2 proteins
revealed that indeed only LAP2β expression was re-
duced, without affecting the expression of the other iso-
forms (data not shown). LAP2β shRNA retro viral infected
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individual clones were isolated for further analyses. Two
clones demonstrated significantly reduced LAP2β RNA
(Figure 1A) and protein (Figure 1B) expression levels. Both
clones were investigated for DNA content and karyotype
analyses. DNA index (DI) analysis was performed by flow
cytometry to measure the DNA content of the cells. DIs of
3.312 and 3.206 were found in LAP2β KD clones 1 and 2,
respectively, almost double than 1.715 and 1.776 that were
obtained in untreated and scrambled cells, respectively
(Figure 2). This indicates that LAP2β KD cells underwent
duplication of DNA content as a result of LAP2β reduced
protein level. In order to eliminate the possibility that the
nearly doubled DI of the LAP2β KD clones is due to binu-
cleated U2OS cells, we examined the cell morphology of
these clones, compared with untreated and scrambled cells.
As can be seen in Additional file 1: Figure S1, binucleated
cells were not present in control cells as well as in LAP2β
KD clones.A Mean G1 diploid cells – 62.3































Mean G1 diploid cells – 58.2
Mean G1 LAP KD1 cells – 192.8
DI – 3.312
Figure 2 DNA Index values determination by flow cytometry. The hist
cycle of U2OS cells (red) versus control normal diploid cells (green) and the
the ratio between mean G1 fluorescence level in U2OS and normal cells. D
untreated (A), scrambled control (B) U2OS cells.We next performed fluorescence in situ hybridization
(FISH) to examine the observed DNA content duplica-
tion, using centromeric probes for chromosomes 8, 10,
12 and 17. Duplication of modal centromeres numbers
was demonstrated for all tested chromosomes (Figure 3).
Small population (≤10%) of cells with duplicated centro-
mere numbers also were found in untreated and
scrambled control U2OS cells, a phenomenon which is
documented in the literature for this cell line [18]. It is
important to note, that we observed, using FISH, the
same DNA duplication using the non- viral RNAi ap-
proach, reinforcing our hypothesis that polyploidy was
obtained as a consequence of LAP2β reduced level
(Additional file 2: Figure S2). The polyploid phenotype
was not observed by us when the expression of LAP2β
was reduced using the RNAi approach in another cancer
cell line, HepG2, as well as in the diploid primary arising
retinal pigment epithelia (ARPE) cells (Additional file 3:
Figure S3).B Mean G1 diploid cells – 57.6





Mean G1 diploid cells – 58.2
Mean G1 LAP KD2 cells – 186.5
DI – 3.206
ograms represent the percentage of cells in each phase of the cell
Propidium Iodide (PI) fluorescence level. The final DI is calculated as
oubled DI was measured in LAP2β KD clones 1 (C) and 2 (D) versus






























Chr. 8 Chr. 10 Chr. 12 Chr. 17
Figure 3 Centromere signal numbers upon LAP2β KD in U2OS cells. (A) FISH hybridization pattern of centromeres of chromosomes 10 and
12. (B) Quantification of centromeric signal numbers of the same chromosomes, based on analyses of 300 cells in each sample.
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and single chromosomal markers
To evaluate whether the chromosomal duplication pheno-
type of LAP2β KD cells represent a phenotype of the entire
genome in these cells, we chose to use spectral karyotyping
(SKY) analysis. Comparison between chromosome num-
bers per metaphase revealed about two fold duplication
upon LAP2β KD. Near-triploid metaphases of untreated
and scrambled control consisted an average of 70 ± 5.48
(range 58-79) and 69 ± 4.13 (range 57-78) chromosomes,
respectively, whereas LAP2β KD near-hexaploid meta-
phases consisted an average of 138 ± 7.32 (range 127-150)
and 136 ± 6.41 (range 131-150) chromosomes, in LAP2β
KD1 and KD2 clones, respectively (Figure 4). The wide
range of chromosome number in each clone resulted also
from the presence of small chromosomes which contained
centromeres, a phenomenon that was reported in other
cytogenetic studies [18]. The classification of these centro-
meres according to DAPI banding and SKY image is com-
plicated, therefore in our karyotype characterizations we
did not assign them as clear chromosomal markers. TheSKY analyses showed that the karyotypes of untreated and
scrambled U2OS cells was characterized by high level of
structural and numerical chromosomal alterations, a
phenomenon which is described in the literature for this
cell line [19]. We therefore focused on clear, well defined
chromosomal markers, where the involvement of specific
chromosomes was confirmed by FISH using whole
chromosome painting probes. The SKY analyses showed
that the karyotypes of LAP2β KD clones 1 and 2 are
characterized by seven double chromosomal markers
(Figure 5A, A1-A7 in yellow), namely, der(1)t(1;21)×2,
der(4)t(4;22)×2, der(6)t(6;10)×2, der(7)t(7;14)×2, der(8)t
(8;12)×2, der(13)t(13;15)×2 and der(15)t(15;2)×2, and four
single chromosomal markers (Figure 5A, B-E in green),
namely der(2)t(2;19;18), der(9)t(9;15), der(9)t(9;8) and der
(X)t(X;18). Furthermore, SKY analysis revealed that the
both characterized U2OS sub-clones, U2OS-1 and
U2OS-2, contained the seven markers that were dupli-
cated in LAP2β KD, but the four single chromosomal
markers were detected only in U2OS-2 (Figure 5C)


























Figure 5 Duplicated and single chromosomal markers in LAP2β KD karyotypes. Representative karyotypes from LAP2β KD clone 1 (A) and
two sub-clones of untreated (B, C) U2OS cells (U2OS-1 and U2OS-2, respectively). The frames are around chromosomal markers: A1-A7 (yellow)
which are common in all the sub-clones and are duplicated upon LAP2β KD; B-E (green) which are typical only for one sub-clone and stay as





Figure 4 Duplication of chromosomes number in U2OS LAP2β KD cells. Representative SKY images (RGB display) from untreated (A),
scrambled control (B), LAP2β KD clone 1 (C) and 2 (D). A’-D’–the inverted DAPI images.
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genes in LAP2β KD cells
To elucidate changes in gene expression in U2OS cells
upon LAP2β KD, microarray expression profiling of
Human transcriptome (Affymetrix GENE1.0 ST oligo-
nucleotide array) was performed. Comparison of gene ex-
pression profiles between LAP2β KD clones and scrambled
control yielded a list of 342 genes that exhibited signifi-
cantly 2 fold down or up-regulation in both LAP2β KD
U2OS clones (Figure 6A, Additional file 4: Table S1). The
expression profile of 4 of the changed genes, ATR, MYC,
CENP1 and PMF1 was validated by qPCR (Figure 6B) and
was found to be consistent with the levels detected by the
microarray analysis (Figure 6C). The 342 gene list was
analyzed for functional annotation clustering using two bio-
informatic analysis tools, Ingenuity and DAVID. The top
functional ‘Ingenuity’ categories that were most significantly
affected in LAP2β KD cells are summarized in Table 1.
They included ‘cell cycle’ and ‘DNA replication, recombin-
ation, and repair’ groups which are relevant to chromo-
somal integrity and maintenance of ploidy (Additional
file 4: Table S2). The most significant category of disease,
consisting of the highest number of genes, was found to be
cancer (Table 2, Pv = 1.58E-06, 108 genes). 31.6% of
the genes in this group are involved in aspects of wors-
ening and progression of cancer, such as apoptosis
(Pv = 4.40E-04), colony formation (Pv = 2.02E-06), invasion
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Figure 6 Differentially expressed genes in LAP2β KD cells. A. The clust
(green) or up (red) regulated by two fold or more in both LAP2β KD U2OS
assayed in triplicates for each sample. All values were normalized to the re
the four validated genes as obtained by microarray and RQ-PCR analyses.Discussion
LAP2β, the major LAP2 family nuclear membrane iso-
form, is mainly recognized for its essential roles in tran-
scriptional repression at the NE (reviewed in [12]) and
promotion of NE breakdown and reassembly during mi-
tosis [20]. Here we show by using the RNAi approach
that individual U2OS clones stably depleted of LAP2β
are characterized by duplicated DNA content and num-
ber of chromosomes, as was documented by flow cytom-
etry, FISH and cytogenetic analyses. These surprising
findings demonstrate the involvement of an INM protein
in the maintenance of cell ploidy status.
An increased number of whole chromosome sets, poly-
ploidy, especially in its simplest tetraploidy(4n) form, is
highly prevalent in different forms of cancer, particularly in
the early stages, suggesting a role for this phenomenon in
cancer promotion [21,22]. It has been proposed that tetra-
ploid state is an unstable intermediate, which can result in
aneuploidy and cancer (reviewed in [23]). It was shown
that mouse tetraploid cells generated by the process of
telomere-driven tetraploidization are more tumorigenic
then their diploid counterparts [24]. Mouse model of
ovarian cancer provides direct evidence for “diploidy-tetra-
ploidy-aneuploidy” pathway: tetraploid cells arising from
cytokinesis failure of diploid cells display higher rates of
chromosome mis-segregation, compared to their diploid
progenitors, leading to the generation of numerous aneu-
ploid daughter cells [25]. Polyploid cells in a diploid 1 
rambled







er analysis represents the 342 genes that were significantly down
clones. B. Validation of microarray results by RQ-PCR. Four genes were
ference gene RPLPO. C. Comparison table of the expression values of
Table 1 Top functional categories, significantly changed (p < 0.05), ‘Ingenuity’ analysis
Category Functions No. genes P-value
1 Organismal functions Healing 11 5.42E-08–4.70E-03
2 Cellular movement cell movement, chemotaxis, homing, intravasation,
invasion, migration
54 1.58E-06–8.04E-03
3 Cellular growth and proliferation colony formation, growth, hypertrophy, proliferation 81 2.02E-06–8.28E-03
4 Cell to cell signaling and interaction attachment, recruitment, activation, adhesion, penetration 30 1.09E-05–8.36E-03
5 Hair and skin development and function cell movement, development, migration 7 2.05E-05–2.87E-03
6 Cell death apoptosis, cell death, survival 69 2.08E-05–8.16E-03
7 Skeletal and muscular system
development and function
adhesion, cell movement, development,
differentiation, formation, migration, proliferation
20 2.49E-05–6.34E-03
8 Cellular development developmental process/disorder, differentiation,
growth, hypertrophy, tubulogenesis
52 4.66E-05–8.37E-03
9 Cell cycle cell division process, cell stage, G0/G1 phase transition,
G1/S phase transition, G2/M phase transition,
interphase, mitosis
25 5.60E-05–7.53E-03
10 Tumor morphology growth, invasion, proliferation,
regression, size
17 9.06E-05–7.33E-03
11 DNA replication, recombination and repair synthesis, metabolism of DNA 24 1.23E-04–6.94E-03
12 Organismal survival death, survival 42 1.27E-04–3.27E-03
13 Immune response accumulation, cell movement, proliferation 29 1.73E-04–8.04E-03
14 Immune and lymphatic system development
and function
accumulation, development, differentiation, growth,
mitosis, morphology, proliferation, quantity, size
33 1.73E-04–7.91E-03
15 Tissue development accumulation, adhesion, developmental process,
formation
20 1.73E-04–8.15E-03
16 Embryonic development differentiation, quantity, tubulogenesis 14 1.86E-04–4.70E-03
17 Organismal development angiogenesis, developmental process,
neovascularization, size
40 2.62E-04–2.92E-03
18 Gene expression activation, binding, expression, stabilization,
transactivation, transcription
39 2.65E-04–8.08E-03
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fusion, endoreplication and abortive cell cycle including
cytokinesis failure and mitotic slippage [26]. We asked
which of these mechanisms can explain the near-hexaploid
karyotype of our LAP2β depleted U2OS cells. SKY analysis
of these cells revealed that two sets of chromosomes from
two distinct nuclei were jointed. Karyotyping of un-
treated U2OS cells revealed two different near-triploid
sub-clones that can be distinguished by specific chromo-
somal markers. Analysis of LAP2β KD karyotypes revealed
near duplicated number of chromosomes that included two
copies of common chromosomal markers (A1-A7, Figure 5)Table 2 Genes distribution according to their
involvement in diseases (p < 0.05)
Diseases No. genes P-value
1 Cancer 108 1.58E-06–8.16E-03
2 Reproductive system disease 58 9.12E-06–5.65E-03
3 Skeletal and muscular disorders 41 1.03E-05–8.02E-03
4 Gastrointestinal disease 42 1.47E-05–8.01E-03
5 Hematological disease 32 1.77E-05–7.52E-03and only a single copy of chromosomal markers that are
unique to U2OS-2 sub- clone (B-E, Figure 5). The fact that
not all the chromosomal markers were duplicated leads us
to reject the possibility that the polyploid phenotype re-
sulted from whole genome duplication. The chance for
whole genome duplication to occur followed by loss of a
combination of chromosomal markers that characterize the
sub clone, together with the fact that the same combina-
tions of chromosomal markers appeared in different poly-
ploid cells, is very low, thus ruling out this possibility
(Figure 7).
The concept that cell fusion contributes to tumorigen-
esis was proposed more than 100 years ago. In recent
years, a potentially important role of cell fusion in the
tumor progression, including acquisition of metastasis
ability, generation of cancer stem cells and multidrug re-
sistance was suggested [27-31]. It was shown that when
leukemia cells fuse with stromal cells in vivo, the malig-
nant potential of the leukemia cells is maintained in the
resulting hybrid cells that allow assuming of fusion as a
mechanism of gene transfer for cancer dissemination
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Not found Not found
U2OS subclone 1 U2OS subclone 2
Figure 7 Schematic representation of the possible mechanisms producing the polyploid cells upon LAP2β KD. A1-A7 are common
chromosomal markers that exist in two copies upon LAP2β KD. B-E are typical chromosomal markers that stay as single copy in LAP2β KD cells.
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cells play an important role in the generation of metasta-
sis [33]. Based on our study we hypothesise that an aber-
rant expression of LAP2β in cancer cells, such as
osteosarcoma, which U2OS cells derived from, may lead
under certain circumstances to the fusion of these can-
cer cells, either with themselves to promote local tumor
or with bone marrow derived cells to form metastases.
We suggest that the process of fusion between two
distinct nuclei is associated with and rely on the re-
assembly of the NE at the end of mitosis. LAP2β has a
pivotal role during mitosis in governing NE breakdown
and reassembly [20,34]. In late anaphase the two new
NEs start to form around each segregated mass of chro-
matin, such that nuclear reassembly is completed in
telophase (for review see [15]). Hetzer and his colleagues
[16] showed that NE reformation timing is important for
proper cell cycle progression and is coordinated with
other mitotic events in anaphase/telophase. Moreover,
decreasing the expression levels of LAP2β, LBR or
MAN1 in U2OS cells delayed NE reformation, while the
over expression of these proteins accelerated this process
and interfered with chromosomal segregation during mi-
tosis. Knocking down the expression of one of the INM
proteins could be rescued by the over expression of a
different chromatin binding INM counterpart or by in-
creasing BAF or LBR protein levels. The fact that reduc-
tion of one of the INM proteins is unable to completely
block NE formation is indicative for a redundant system
in which NE reassembly is accomplished even in the ab-
sence of one of the proteins, possibly at a slower rate
[16]. Considering this, and our obtained results, we
propose a model (Figure 8) suggesting that in LAP2β
KD fused U2OS cells there is a delay in NE reassembly
which allows the fusion of nuclear contents of the fusedcells before two new NEs are formed around the two nu-
clei of the fused cells. In this case, cytokinesis event is
abolished because only one nucleus is formed and envel-
oped. However, due to INM redundancy in the process
of NE reassembly, at the next mitotic round, the loss of
LAP2β may be compensated by other INM LEM pro-
teins, such as LBR, MAN1 and emerin, or by lamin B1
and other proteins of the nuclear lamina, allowing
NE breakdown and reassembly to be carried out
undisturbed.
According to our suggested model (Figure 8), despite a
compensation mechanism at the NE, the LAP2β de-
pleted cells remain in an irreversible polyploid pheno-
type because of the initial damage. It is also possible that
nuclear fusion events continue to occur, resulting in a
greater chromosomal instability and aneuploidy, not
compatible with living cells in the culture, driving them
to cell death. This may imply on a unique role for
LAP2β in guarding the cell from unwanted fusion of two
distinct nuclei contents, an initial event that can lead to
tumorigenesis. Our hypothesized link between LAP2β
depletion, polyploidization and the resulting cancer pro-
gression in osteosarcoma derived cells is reinforced by
the microarray results. Further functional analysis of the
specific genes that were expressional deregulated upon
LAP2β knock down are needed to substantiate this link.
Interestingly, the polyploid phenotype was not observed
by us when the expression of LAP2β was reduced in an-
other non-diploid cell line, HepG2, and in the diploid
primary ARPE cells. We speculate that a specific genetic
or epigenetic background existing in U2OS, and not in
the other two examined cell lines, predispose these can-
cerous cells to enhanced nuclear fusion, leading to poly-
ploidy upon additional cellular aberrations, such as
reduced expression of LAP2β at the NE.
Compensation by other INM proteins’ overexpression 
prevents the continuation of polyploidization? 
Polyploidy induction
Second mitotic round
First mitotic round, 
late anaphase










LAP reduced expression in U2OS cells – suggested model 
Figure 8 Suggested model for polyploidization by nuclear fusion mechanism in U2OS LAP2β KD cells.
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that in tetraploid/polyploidy tumor cells, when single
rearranged chromosomes are found [19,35-39] it may be
the result of fusion between two heterogeneous cancer
cells, rather than the formation of chromosome re-
arrangement, occurring on the tetraploid/polyploidy per
se. Therefore, we hypothesize that in the progression of
cancer, cell fusion events are much more frequent than
suggested previously. We suggest not to rule out the
possibility of cell fusion mechanism when chromo-
somal changes are cytogenetically analyzed during can-
cer progression.
Conclusions
The presented results in this study suggest that nuclear
fusion mechanism underlies the polyploidization induc-
tion upon LAP2β reduced expression in U2OS cells.
Our study implies on a novel role of an INM protein,
LAP2β, in the maintenance of cell ploidy status in U2OS
cells. Thus, LAP2β depleted U2OS cells can serve as a
model to investigate polyploidy and aneuploidy forma-
tion by nuclear fusion mechanism and its involvement
in cancer initiation and progression. Such a cellular
model can also enhance our understanding of nuclear
fusion mechanism and the importance of nuclear enve-
lope reassembly timing at the end of mitosis.
Methods
Cell lines
The human osteosarcoma cell line U2OS , embryonic kid-
ney (HEK293T) and hepatocellular carcinoma HepG2 cells
were cultured in Dulbecco’s modified Eagle’s medium(DMEM) (Biological Industries, Israel) supplemented with
10% fetal calf serum (FCS), 2 mM glutamine, 100 mg/ml
streptomycin and 100 units/ml penicillin (Biological Indus-
tries). Human retinal pigmented epithelium (ARPE) cells
were cultured with a 1:1 mixture of Dulbecco’s modified
Eagle’s medium and Ham’s F12 medium (Sigma Aldrich)
with 3 mM glutamine, 10% fetal bovine serum. All cells
were grown at 37°C in a humidified incubator with 5%
CO2.
Transfection and viral infection
pSuper shRNA retro-viral (a generous gift from Prof. Shai
Izraeli, Sheba cancer research center, Tel-Hashomer, Israel)
and non-viral (a generous gift from Prof. Reuven
Agami, The Netherlands Cancer Institute, Amsterdam,
The Netherlands) systems were used to generate LAP2β
stable knocked down (KD) in the U2OS cell line. shRNA
oligonucleotides sequences were designed based on LAP2β




GGAAA-3′, Reverse 5′- AGCTTTTCCAAAAACTGA
GACTGAATGGACAAGTCTCTTGAACTTGTC-
CATTCAGTCTCAGGGG -3′.
Virions for infection were produced by co-transfection of
293T cells with the targeting LAP2β plasmid or non-
targeting scrambled plasmid and packaging proteins
(pMD2G plasmid for Gag-Pol proteins and pCGP for Env)
using FUGENE6 transfection reagent (Roche Diagnostics)
according to manufacturer’s instructions. 48 hours post the
first infection, 2 μg/ml Puromycin (Sigma) was added for
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selection media and were analyzed for LAP2β KD using
western blot and RQ-PCR analyses.Nuclear protein extraction
Untreated, scrambled control and LAP2β KD U2OS cells
were plated at 106 cells in a 10 cm plate. Cells were har-
vested, washed twice with cold PBS, pelleted and resus-
pended and incubated in 400 μl of an ice-cold hypotonic
buffer (10 mM Hepes pH 7.9, 10 mM KCl, 1 mM EDTA,
1 mM EGTA, 0.1 M DTT and protease inhibitors
(‘Complete’, Roche Molecular Biochemicals, Manheim,
Germany)) for 15 min. on ice. 25 μl of 10% NP-40 were
added and cells were vortexed vigorously for 10 sec. and
pelleted at 14,000 RPM for 1 min. at 4°C. The super-
natant containing the cytoplasmatic proteins was sepa-
rated from the pelleted nuclear fraction, taken into a
different tube. The pelleted nuclear fraction was resus-
pended in 200 μl of ice-cold lysis buffer (20 mM HEPES
pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 0.1 M
DTT and protease inhibitors) and was mixed vigorously
for 15 min. at 4°C. Samples were centrifuged at 14,000
RPM for 5 min. at 4°C and the nuclear supernatant was re-
moved to a different tube. Protein concentration of each
sample was determined by Bradford modified method
(BCA Protein Assay kit, Pierce, Rockford, IL, USA) and
equal amounts of proteins were subjected to Western blot
analysis.Western blotting
Proteins were separated on a 10% SDS-PAGE gel
(Invitrogen, USA) in tris glycine running buffer, transferred
to a nitrocellulose membranes using iBlot® Dry Blotting
System (Invitrogen) and detected using the ECL chemilu-
minescence reagent plus (Pharmacia Biotech, NJ, USA).
The following primary antibodies were used: mouse mono-
clonal anti LAP2β (clone 6G11, dilution 1:2500) and poly-
clonal goat anti β-actin (1:1000, Santa Cruz Biotechnology).
Secondary antibodies used were peroxidase-conjugated
goat anti-mouse and peroxidase-conjugated donkey anti-
goat (Jackson Immuno-Research Laboratories, USA) di-
luted 1:10,000 and 1:5,000, respectively.RNA extraction and Reverse transcription PCR
Total RNA was extracted from LAP2β KD, scrambled
and untreated U2OS cells that were grown in 10 cm cul-
ture dishes to a confluence of 90%, using TRIzol reagent
(invitrogen) according to manufacturer’s instructions.
First-strand cDNA was generated from 2 μg of total
RNA in the presence of random hexamer primers using
M-MLV reverse transcriptase (Invitrogen) according to
manufacturer’s instruction.Real-time quantitative PCR
Gene expression was quantified by real-time PCR (RQ-
PCR) using SYBR green PCR Master Mix (Applied Bio-
systems) for LAP2β and Importin (control reference
gene). The primers used are as follows (5′ to 3′, final
concentration 500 nM): Importin forward: TGGGCCCT
CTCATATCTATCA, Importin reverse: CCACTTTAT
AATCATTATGCA, LAP2β forward: CGGACCTCTG
CAGGCATTAAC, LAP2β reverse: TTATAGTTTCAG
CTATGGGAGTACTCTCTG. All the reactions were
performed in triplicates using the ABI Prism 7900 SDS
instrument (Applied Biosystems). Relative gene expres-
sion values were determined using the 2-ddCt method ac-
cording to the manufacturer’s instruction.
DNA index (DI) analysis by flow cytometry
DNA content of U2OS nuclei was measured on a FACS-
can flow cytometer (Becton-Dickinson, Sunnyvale, CA).
DIs were determined by mixing the cells of interest with
normal human diploid leukocytes, followed by propi-
dium iodide (PI) staining (Beckman coulter, USA). PI as
a fluorescent dye binds stoichiometrically to the DNA so
the fluorescence data is considered as a measurement of
the cellular DNA content. Normal diploid cells behave
as reference to identify the position of cells with normal
diploid amount of DNA [40]. According to PI staining of
U2OS and normal diploid mix cells, cell cycle histo-
grams of each cells population with the fluorescence
emitted level in each phase (G0/G1, S, G2/M) were ob-
tained. DI of each sample of U2OS cells is calculated as
the fluorescence level of G0/G1 U2OS cells relative to
the G0/G1 peak of normal diploid cells.
Fluorescence in situ hybridization (FISH)
Directly labled centromeric DNA probes for chromosomes
8, 10, 12 and 17 (Vysis, Downers, Grove, IL and Kreatech,
Amsterdam, The Netherlands) and whole chromosome
painting probes (Applied Spectral imaging (ASI), Migdal
HaEmek, Israel) for chromosomes 2,7,8,9,10,15,18 and 19
were hybridized according to the manufacturer’s instruc-
tions. At least 300 cells were analyzed in each sample.
Slides were analyzed using an Olympus IX81 fluores-
cence light microscope (Olympus, Tokyo, Japan) equipped
with a Plan Apo objective 100x/1.4 oil, an appropriate spec-
tral filter [BH2-TFC1 Triple Band filter DAPI (4,6-diami-
dino 2-phenyl-indole)/FITC (fluorescein isothiocyanate)/
TRITC (tetramethylrhodamine isothiocyanate)], and a
100 W mercury arc lamp.
Spectral karyotyping (SKY)
SKY was performed with the SKY fluorescent labeling
kit (Applied Spectral Imaging, Migdal HaEmek, Israel)
according to the manufacturer’s protocol. Chromosomes
were counterstained with DAPI. Image acquisition was
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Spectral Imaging) mounted on an Olympus BH-2 micro-
scope using a custom-designed optical filter (SKY-1,
Chroma Technology, Brattleboro, VT). Automatic identifi-
cation of chromosomes was based on the measurement of
the spectrum for each chromosome as described previously
[36]. At least 20 metaphase cells were analyzed for each of
U2OS untreated, scrambled and LAP2β KD clones.
Microarray hybridization and data analysis
Experiments were performed using Affymetrix GeneChip
Human Gene 1.0 ST Arrays according to manufacturer’s
recommendations. Briefly, 100-600 ng of total RNA from
LAP2β KD clones and scrambled control cells was used to
generate first-strand cDNA using random hexamers pri-
mer. After second-strand synthesis, in vitro transcription
was performed. The resulting cRNA was then used for a
second cycle of first-strand cDNA with UTP resulting in
single-stranded DNA which was used for fragmentation
and terminal labeling. cDNA generated from each sample
was processed as per manufacturer’s recommendation
using an Affymetrix GeneChip Instrument System manual
(https://www.affymetrix.com/support/downloads/manuals/
wt_sensetarget_label_manual.pdf).
Gene level RMA sketch algorithm (Affymetrix Expres-
sion Console and Partek Genomics Suite 6.2) was used
for crude data generation. Genes were filtered according
to a two fold cutoff up or down regulation and analyzed
using unsupervised hierarchical cluster analysis (Spotfire
DecisionSite for Functional Genomics; Somerville, MA)
to get a first assessment of the data. Further processing
includes functional analysis and over-representation cal-
culations based on Gene Ontology and DAVID [41,42].
Over-representation calculations were done using Ease
(DAVID) and Ingenuity IPA software builds protein
interaction networks (Ingenuity® Systems, www.ingenu-
ity.com). Data results are deposited in http://www.ncbi.
nlm.nih.gov/geo/.
Additional files
Additional file 1: Figure S1. U2OS cells morphology. Light microscopy
observation of untreated, scrambled control and LAP2β KD U2OS cells.
All images were taken using X10 magnification.
Additional file 2: Figure S2. FISH analysis of non-viral LAP2β shRNA
transfected U2OS cells. FISH pattern using whole chromosome probes of
chromosomes 2, 3, 17 and 18 in untreated (Unt.) and LAP2β KD cells.
Additional file 3: Figure S3. FISH analysis of chromosome numbers
upon LAP2β KD in HepG2 and ARPE cells. A - western blot analysis of
HepG2 nuclear protein extracts of untreated, scrambled and two LAP2β
KD clones using mouse anti LAP2β mAb (6G11 clone). β-Actin was used
for equal loading control (I). FISH pattern of centromeres of chromo-
somes 10 and 12 (II). B–western blot analysis of ARPE nuclear protein ex-
tracts of untreated and two LAP2β KD clones using mouse anti LAP2β
mAb (6G11 clone) (III). B–FISH pattern using whole chromosome 3 paint-
ing probe (IV).Additional file 4: Table S1. A complete list of significantly up and
down regulated genes in LAP2β KD U2OS cells. Microarray analysis was
used to compare relative transcript levels between LAP2β KD clones and
scrambled U2OS cells as described in material and methods. The table
lists 342 genes that were up or down regulated at least 2 fold in both KD
clones. Data is provided as fold change in gene expression, relative to
scrambled control. Table S2. List of functional groups and genes related
to cell fusion in LAP2β KD U2OS cells. Bioinformatic analyses were
performed using ‘Ingenuity’ and ‘DAVID’ algorithms.
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